Susan Laura Smith is SVP & CHIEF COMMERCIAL OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 33,918 shares of YMAB, which is worth approximately $504,360. The most recent transaction as insider was on Mar 05, 2024, when has been sold 1,682 shares (Common Stock) at a price of $16.55 per share, resulting in proceeds of $27,837. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.9K
0% 3M change
90.55% 12M change
Total Value Held $504,360

Susan Laura Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$27,837 $16.55 p/Share
1,682 Reduced 4.72%
33,918 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
17,800 Added 33.33%
35,600 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
17,800 Added 50.0%
17,800 Common Stock
SLS

Susan Laura Smith

SVP & CHIEF COMMERCIAL OFFICER
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB